Inactive Instrument

Calendar InMed Pharmaceuticals Inc Deutsche Boerse AG

Equities

CA13764X1069

End-of-day quote Deutsche Boerse AG
- EUR - Intraday chart for InMed Pharmaceuticals Inc

Chart calendar InMed Pharmaceuticals Inc

40ac61e4edf248668d28b1e4.l50z1WHmY5f8sWVKnyX3NwdmL3Q5a0GB9jcepeQ16so.39p74BmcN_2GnB8f6mqlfEFXey1jWCrUjAF44aBDnqynqnnsJtUv7sTlVQ~169d142143b005fe270996c628cf1315

Upcoming events on InMed Pharmaceuticals Inc

20/09/2024 Q4 2024 Earnings Release (Projected)
08/11/2024 Q1 2025 Earnings Release (Projected)
18/02/2025 Q2 2025 Earnings Release (Projected)
14/05/2025 Q3 2025 Earnings Release (Projected)

Past events on InMed Pharmaceuticals Inc

13/06/2024 11:15 pm Emerging Growth Conference
14/05/2024 06:06 pm Q3 2024 Earnings Release
01/05/2024 Webull Biotech Investment Webinar
14/02/2024 04:11 am Q2 2024 Earnings Release
30/01/2024 Microcap Conference
25/01/2024 11:30 pm Water Tower Research Fireside Chat
20/12/2023 03:30 am Annual General Meeting
14/11/2023 06:34 pm Q1 2024 Earnings Release
08/11/2023 02:38 am Itch World Congress
29/09/2023 10:51 pm Q4 2023 Earnings Release
27/09/2023 Benzinga Cannabis Capital Conference
11/09/2023 04:30 pm H.C. Wainwright Global Investment Conference
01/06/2023 09:00 pm Investor Summit
31/05/2023 09:30 pm Tribe Public Conference
28/05/2023 Canadian Neuroscience Meeting
23/05/2023 10:30 pm Water Tower Research Fireside Chat
16/05/2023 02:15 am Q3 2023 Earnings Release
09/03/2023 09:30 pm OTC Life Science Investor Forum
08/03/2023 10:30 pm Emerging Growth Conference
18/02/2023 04:00 am Interim 2023 Earnings Release

Annual results

Fiscal PeriodJune 2019 2020 2021 2022 2023 2024
Net sales
Million CAD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
1,48
1,71
-13.73%
5,59
5,44
2.75%

7,30

EBITDA
Million CAD
Released
Forecast
Spread
-13,5
-8,98
-50.59%
0,00
0,00
-
-12,4
-12,5
0.12%
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million CAD
Released
Forecast
Spread
-13,6
-10,8
-26.51%
-12,1
-13,9
12.94%
-12,6
-12,1
-3.8%
-18,7
-17,9
-4.27%
-11,3
-12,6
9.78%

-13,7

Earnings before Tax (EBT)
Million CAD
Released
Forecast
Spread
-13,3
-12,6
-5.53%
-11,9
-13,5
12.36%
-12,9
-13,0
0.28%
0,00
0,00
-
0,00
0,00
-

0,00

Net income
Million CAD
Released
Forecast
Spread
-13,3
-12,4
-6.56%
-11,9
-13,5
12.36%
-12,9
-13,0
0.28%
0,00
0,00
-
0,00
0,00
-

0,00

EPS
CAD
Released
Forecast
Spread
-66,0
-57,8
-14.29%
-56,8
-66,0
14.02%
-48,2
-49,3
2.1%
0,00
0,00
-
0,00
0,00
-

0,00

Announcement Date19/09/1908/09/2024/09/2123/09/2229/09/23-

Quarterly results

Fiscal PeriodJune 2022 Q3 2022 Q4 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million CAD
Released
Forecast
Spread
0,40
0,77
-47.34%
0,70
0,97
-28%



3,13
3,04
2.88%
1,24
1,89
-34.38%
1,68
1,52
10.79%
1,60
2,01
-20.17%

2,41

EBIT
Million CAD
Released
Forecast
Spread
-4,85
-4,48
-8.22%
-4,13
-4,05
-2.13%



-0,70
-2,96
76.39%
-3,62
-2,83
-27.95%
-2,31
-3,26
29.16%
-2,45
-2,88
14.74%

-5,03

Net income
Million CAD
Released
Forecast
Spread






-2,70

















EPS
CAD
Released
Forecast
Spread






-0,81

















Announcement Date13/05/2223/09/2215/05/2329/09/2314/11/2313/02/2414/05/24-
  1. Stock Market
  2. Equities
  3. INM Stock
  4. Stock
  5. Calendar InMed Pharmaceuticals Inc